Sujatha Manthri
Dundee, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Identification of potent inhibitors of Leishmania donovani and Leishmania infantum chagasi, the causative agents of Old and New World visceral leishmaniasis.
Journal: Communications biology
Published: September 23, 2024
Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.
Journal: Nature
Published: July 04, 2023
Scaffold-Hopping Strategy on a Series of Proteasome Inhibitors Led to a Preclinical Candidate for the Treatment of Visceral Leishmaniasis.
Journal: Journal of medicinal chemistry
Published: April 27, 2021
Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent In Vitro Antileishmanial Activity: Initial SAR and Assessment of In Vivo Activity.
Journal: Journal of medicinal chemistry
Published: July 15, 2020
Identification of 6-amino-1H-pyrazolo[3,4-d]pyrimidines with in vivo efficacy against visceral leishmaniasis.
Journal: RSC medicinal chemistry
Published: June 12, 2020
The Qi Site of Cytochrome b is a Promiscuous Drug Target in Trypanosoma cruzi and Leishmania donovani.
Journal: ACS infectious diseases
Published: January 23, 2020
Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 10, 2019
Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis.
Journal: Journal of medicinal chemistry
Published: December 21, 2018
Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani.
Journal: ACS infectious diseases
Published: November 02, 2018
Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani.
Journal: ACS infectious diseases
Published: October 03, 2017
Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.
Journal: Nature
Published: August 09, 2017
Development and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity.
Journal: PLoS neglected tropical diseases
Published: March 26, 2015
Showing 1-12 of 12
Last Updated: 09/26/2026